Clinical Trial Update: A Real-world Study to Compare the Effectiveness of Sacubitril/Valsartan Versus ACEi/ARB in HFrEF Patients

View source ↗

Summary

A completed real-world study comparing the effectiveness of sacubitril/valsartan versus ACE inhibitors/ARBs in patients with heart failure with reduced ejection…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Reduced Ejection Fraction

Drugs mentioned

• Sacubitril/Valsartan (sacubitril/valsartan)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Heart Failure | Status: COMPLETED